Aberrant methylation in lung cancer identified by EBUS-TBNA as a marker of advanced staging
Laura Millares, Laia Setó, José Sanz, Mariona Llatjos, Felipe Andreo, Eva Castellà, Eduard Monsó
European Respiratory Journal 2012 40: P4400; DOI:
Laura Millares
1Pneumology, CIBERES, Germans Trias i Pujol Health Sciences Research Institut, Badalona, Barcelona, Spain
Laia Setó
2Pneumology, CIBERES, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
José Sanz
2Pneumology, CIBERES, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Mariona Llatjos
2Pneumology, CIBERES, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Felipe Andreo
2Pneumology, CIBERES, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Eva Castellà
2Pneumology, CIBERES, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
Eduard Monsó
3Pneumology, CIBERES, Corporació Parc Tauli, Sabadell, Barcelona, Spain
Vol 40 Issue Suppl 56
Table of Contents
Aberrant methylation in lung cancer identified by EBUS-TBNA as a marker of advanced staging
Laura Millares, Laia Setó, José Sanz, Mariona Llatjos, Felipe Andreo, Eva Castellà, Eduard Monsó
European Respiratory Journal Sep 2012, 40 (Suppl 56) P4400;